Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3).
about
In vivo analysis of Lrig genes reveals redundant and independent functions in the inner earThe LRIG family: enigmatic regulators of growth factor receptor signaling.LRIG and cancer prognosis.Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth.LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells.HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.LRIG1 is a prognostic biomarker in non-small cell lung cancer.Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.Heparanase 2, mutated in urofacial syndrome, mediates peripheral neural development in Xenopus.Feedback regulation of RTK signaling in development.A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors.Glycosylation Changes in Brain Cancer.Cardiac hypertrophy and decreased high-density lipoprotein cholesterol in Lrig3-deficient mice.
P2860
Q27320101-00E66F0C-CA3B-4450-A441-9CE8A0C8C69DQ34276176-BCFEB3D1-75C1-45FA-8E1B-EBBA8EE87E15Q35626430-6D83B213-6DE8-4BA7-AB86-48E1C246E2D0Q36437261-9681C0A5-3DC4-4E59-9F6B-23B1AB0F32CAQ36723368-40F3B8B6-DBB6-4445-BD52-919270905E21Q36751137-F0D7FEDB-3DD0-478B-9168-56B2065CF35BQ39024741-C5D7EA75-5C18-4DA7-9F7A-9E3087217D58Q40070276-83EBA41B-B16C-4C44-8D5F-4B7F3951F369Q42259092-3533EC0D-A56E-4897-A078-5CE34C3C27B4Q46578462-60611158-033A-4FE8-9D2B-ADE0FC65A6C8Q47215868-6BAB9862-0B84-45A1-B828-61BA5F26F6E9Q47691736-DEC05B0A-FAFA-4400-BFC4-37FDEA9D6AB0Q50916387-6741434F-C536-4FD7-8DC0-B985495F6386
P2860
Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Leucine-rich repeat and immuno ...... -containing protein 3 (Lrig3).
@en
Leucine-rich repeat and immunoglobulin domain-containing protein-1
@nl
type
label
Leucine-rich repeat and immuno ...... -containing protein 3 (Lrig3).
@en
Leucine-rich repeat and immunoglobulin domain-containing protein-1
@nl
prefLabel
Leucine-rich repeat and immuno ...... -containing protein 3 (Lrig3).
@en
Leucine-rich repeat and immunoglobulin domain-containing protein-1
@nl
P2093
P2860
P356
P1476
Leucine-rich repeat and immuno ...... -containing protein 3 (Lrig3).
@en
P2093
Colleen Sweeney
Francisco Mercado
Hanine Rafidi
Kermit L Carraway
Matthew Saldana
Michael Astudillo
William H D Fry
P2860
P304
21593-21605
P356
10.1074/JBC.M113.486050
P407
P577
2013-05-30T00:00:00Z